Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Glycemia and Childhood Glucose Metabolism
Open accessAbstract
OBJECTIVE: This study examined associations of maternal glycemia during pregnancy with childhood glucose outcomes in the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) cohort. RESEARCH DESIGN AND METHODS: HAPO was an observational international investigation that established associations of maternal glucose with adverse perinatal outcomes. The HAPO Follow-up Study included 4,832 children ages 10–14 years whose mothers had a 75-g oral glucose tolerance test (OGTT) at ∼28 weeks of gestation. Of these, 4,160 children were evaluated for glucose outcomes. Primary outcomes were child impaired glucose tolerance (IGT) and impaired fasting glucose (IFG). Additional outcomes were glucose-related measures using plasma glucose (PG), A1C, and C-peptide from the child OGTT. RESULTS: Maternal fasting plasma glucose (FPG) was positively associated with child FPG and A1C; maternal 1-h and 2-h PG were positively associated with child fasting, 30 min, 1-h, and 2-h PG, and A1C. Maternal FPG, 1-h, and 2-h PG were inversely associated with insulin sensitivity, whereas 1-h and 2-h PG were inversely associated with disposition index. Maternal FPG, but not 1-h or 2-h PG, was associated with child IFG, and maternal 1-h and 2-h PG, but not FPG, were associated with child IGT. All associations were independent of maternal and child BMI. Across increasing categories of maternal glucose, frequencies of child IFG and IGT, and timed PG measures and A1C were higher, whereas insulin sensitivity and disposition index decreased. CONCLUSIONS: Across the maternal glucose spectrum, exposure to higher levels in utero is significantly associated with childhood glucose and insulin resistance independent of maternal and childhood BMI and family history of diabetes.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 23 cited sources checked · 0 supported · 0 flagged
- Findingown data
Maternal 1-h plasma glucose during pregnancy is positively associated with child fasting plasma glucose.
“Maternal 1-h and 2-h PG were positively associated with child fasting, 30 min, 1-h, and 2-h PG, and A1C.”
- Also stated in: § Associations Between Continuous Maternal Glycemia and Continuous Child Glucose Outcomes · plain
“Maternal 1-h and 2-h PG during the pregnancy OGTT and maternal sum of glucose z scores were positively associated with all child glucose measures and A1C in all models”
Quote in the paperSubstantial claim - Also stated in: § Associations Between Continuous Maternal Glycemia and Continuous Child Glucose Outcomes · plain
- Findingown data
Maternal fasting plasma glucose during pregnancy is positively associated with child A1C.
“Maternal fasting plasma glucose (FPG) was positively associated with child FPG and A1C”
- Also stated in: § Associations Between Continuous Maternal Glycemia and Continuous Child Glucose Outcomes · plain
“Maternal FPG was positively associated with child FPG, 30-min PG, the sum of glucose z scores, and A1C.”
Quote in the paperSubstantial claim - Also stated in: § Associations Between Continuous Maternal Glycemia and Continuous Child Glucose Outcomes · plain
- Findingown data
Maternal sum of glucose z scores was inversely associated with the child insulinogenic index only after adjustment for maternal BMI alone or together with child BMI z score in models 2 and 4.
“Maternal sum of glucose z scores was inversely associated with child insulinogenic index only after adjusting for maternal BMI alone or together with child BMI z score (models 2 and 4).”
Quote in the paperNot a substantial claim - Findingown data
Interaction terms between maternal glucose levels and Tanner stage were not statistically significant.
“Although interaction terms between maternal glucose levels and Tanner stage were not statistically significant”
Quote in the paperNot a substantial claim - Findingown data
Maternal 2-h plasma glucose during pregnancy is inversely associated with child disposition index.
“Maternal FPG, 1-h, and 2-h PG were inversely associated with insulin sensitivity, whereas 1-h and 2-h PG were inversely associated with disposition index.”
Quote in the paperSubstantial claim
- Findingown data
Maternal 1-h plasma glucose during pregnancy is inversely associated with child disposition index.
“Maternal FPG, 1-h, and 2-h PG were inversely associated with insulin sensitivity, whereas 1-h and 2-h PG were inversely associated with disposition index.”
Quote in the paperSubstantial claim - Findingown data
Mean child fasting, 30-min, 1-h, and 2-h plasma glucose, A1C, and sum of glucose z scores were generally higher across increasing categories of maternal fasting, 1-h, and 2-h plasma glucose during pregnancy.
“Means of child fasting, 30-min, 1-h, and 2-h PG, A1C, and the sum of glucose z scores were generally higher across increasing categories of maternal fasting, 1-h, and 2-h PG during pregnancy.”
Quote in the paperSubstantial claim - Findingown data
Across increasing categories of maternal glucose, frequencies of child impaired fasting glucose and impaired glucose tolerance were higher.
“Across increasing categories of maternal glucose, frequencies of child IFG and IGT, and timed PG measures and A1C were higher, whereas insulin sensitivity and disposition index decreased.”
Quote in the paperSubstantial claim - Findingown data
Maternal 2-h plasma glucose during pregnancy is not associated with child impaired fasting glucose.
“Maternal FPG, but not 1-h or 2-h PG, was associated with child IFG, and maternal 1-h and 2-h PG, but not FPG, were associated with child IGT.”
Quote in the paperSubstantial claim - Findingown data
Maternal 2-h plasma glucose during pregnancy is associated with child impaired glucose tolerance.
“Maternal FPG, but not 1-h or 2-h PG, was associated with child IFG, and maternal 1-h and 2-h PG, but not FPG, were associated with child IGT.”
Quote in the paperSubstantial claim - Findingown data
Maternal 1-h plasma glucose was inversely associated with the child insulinogenic index in all models examined.
“However, maternal 1-h PG was inversely associated with the child insulinogenic index in all models”
Quote in the paperSubstantial claim - Findingown data
Maternal 1-h plasma glucose during pregnancy is positively associated with child 2-h plasma glucose.
“Maternal 1-h and 2-h PG were positively associated with child fasting, 30 min, 1-h, and 2-h PG, and A1C.”
- Also stated in: § Associations Between Continuous Maternal Glycemia and Continuous Child Glucose Outcomes · plain
“Maternal 1-h and 2-h PG during the pregnancy OGTT and maternal sum of glucose z scores were positively associated with all child glucose measures and A1C in all models”
Quote in the paperSubstantial claim - Also stated in: § Associations Between Continuous Maternal Glycemia and Continuous Child Glucose Outcomes · plain
- Findingown data
The associations between maternal glucose measures and child glucose outcomes were independent of maternal and child BMI.
“All associations were independent of maternal and child BMI.”
- Also stated in: § Associations Between Continuous Maternal Glycemia and Continuous Child Glucose Outcomes · plain
“Adjusting for maternal BMI at pregnancy OGTT and/or child BMI z score at follow-up did not attenuate these associations.”
Quote in the paperSubstantial claim - Also stated in: § Associations Between Continuous Maternal Glycemia and Continuous Child Glucose Outcomes · plain
- Findingown data
Maternal 2-h plasma glucose was inversely associated with the child insulinogenic index after adjustment for child BMI z score alone or together with maternal BMI in models 3 and 4.
“and maternal 2-h PG was inversely associated with the insulinogenic index after adjusting for child BMI z score alone or together with maternal BMI (models 3 and 4).”
Quote in the paperSubstantial claim - Findingown data
Maternal 2-h plasma glucose during pregnancy is positively associated with child fasting plasma glucose.
“Maternal 1-h and 2-h PG were positively associated with child fasting, 30 min, 1-h, and 2-h PG, and A1C.”
- Also stated in: § Associations Between Continuous Maternal Glycemia and Continuous Child Glucose Outcomes · plain
“Maternal 1-h and 2-h PG during the pregnancy OGTT and maternal sum of glucose z scores were positively associated with all child glucose measures and A1C in all models”
Quote in the paperSubstantial claim - Also stated in: § Associations Between Continuous Maternal Glycemia and Continuous Child Glucose Outcomes · plain
- Findingown data
Adjusted mean differences in models 1 through 4 confirmed linear trends between maternal glucose predictors and child insulin sensitivity and disposition index.
“Adjusted mean differences in models 1–4 confirmed linear trends between maternal glucose predictors and these child outcomes (Supplementary Table 6).”
Quote in the paperSubstantial claim - Findingown data
Maternal 2-h plasma glucose during pregnancy is positively associated with child 2-h plasma glucose.
“Maternal 1-h and 2-h PG were positively associated with child fasting, 30 min, 1-h, and 2-h PG, and A1C.”
- Also stated in: § Associations Between Continuous Maternal Glycemia and Continuous Child Glucose Outcomes · plain
“Maternal 1-h and 2-h PG during the pregnancy OGTT and maternal sum of glucose z scores were positively associated with all child glucose measures and A1C in all models”
Quote in the paperSubstantial claim - Also stated in: § Associations Between Continuous Maternal Glycemia and Continuous Child Glucose Outcomes · plain
- Findingown data
Maternal fasting plasma glucose was not significantly associated with the child disposition index.
“Regarding child β-cell function, maternal FPG was not significantly associated with disposition index”
Quote in the paperNot a substantial claim - Findingown data
Maternal fasting plasma glucose during pregnancy is inversely associated with child insulin sensitivity.
“Maternal FPG, 1-h, and 2-h PG were inversely associated with insulin sensitivity, whereas 1-h and 2-h PG were inversely associated with disposition index.”
Quote in the paperSubstantial claim - Findingown data
Maternal 1-h and 2-h glucose and the sum of OGTT z scores were inversely associated with the child disposition index in all four models.
“but maternal 1-h and 2-h glucose and the sum of OGTT z scores were inversely associated with the child disposition index in all four models.”
Quote in the paperSubstantial claim - Findingown data
Maternal 1-h plasma glucose during pregnancy is positively associated with child 30-min plasma glucose.
“Maternal 1-h and 2-h PG were positively associated with child fasting, 30 min, 1-h, and 2-h PG, and A1C.”
- Also stated in: § Associations Between Continuous Maternal Glycemia and Continuous Child Glucose Outcomes · plain
“Maternal 1-h and 2-h PG during the pregnancy OGTT and maternal sum of glucose z scores were positively associated with all child glucose measures and A1C in all models”
Quote in the paperSubstantial claim - Also stated in: § Associations Between Continuous Maternal Glycemia and Continuous Child Glucose Outcomes · plain
- Findingown data
Maternal 1-h plasma glucose during pregnancy is not associated with child impaired fasting glucose.
“Maternal FPG, but not 1-h or 2-h PG, was associated with child IFG, and maternal 1-h and 2-h PG, but not FPG, were associated with child IGT.”
Quote in the paperSubstantial claim - Findingown data
Across increasing categories of maternal glucose, insulin sensitivity and disposition index decreased.
“Across increasing categories of maternal glucose, frequencies of child IFG and IGT, and timed PG measures and A1C were higher, whereas insulin sensitivity and disposition index decreased.”
Quote in the paperSubstantial claim - Findingown data
Maternal 1-h and 2-h plasma glucose and the sum of glucose z scores were associated with child IGT.
“but maternal 1-h and 2-h PG and the sum of glucose z scores were associated with IGT.”
Quote in the paperSubstantial claim - Findingown data
Maternal 2-h plasma glucose during pregnancy is positively associated with child A1C.
“Maternal 1-h and 2-h PG were positively associated with child fasting, 30 min, 1-h, and 2-h PG, and A1C.”
- Also stated in: § Associations Between Continuous Maternal Glycemia and Continuous Child Glucose Outcomes · plain
“Maternal 1-h and 2-h PG during the pregnancy OGTT and maternal sum of glucose z scores were positively associated with all child glucose measures and A1C in all models”
Quote in the paperSubstantial claim - Also stated in: § Associations Between Continuous Maternal Glycemia and Continuous Child Glucose Outcomes · plain
- Findingown data
Maternal fasting plasma glucose during pregnancy is associated with child impaired fasting glucose.
“Maternal FPG, but not 1-h or 2-h PG, was associated with child IFG, and maternal 1-h and 2-h PG, but not FPG, were associated with child IGT.”
Quote in the paperSubstantial claim - Findingown data
Maternal 2-h plasma glucose during pregnancy is positively associated with child 1-h plasma glucose.
“Maternal 1-h and 2-h PG were positively associated with child fasting, 30 min, 1-h, and 2-h PG, and A1C.”
- Also stated in: § Associations Between Continuous Maternal Glycemia and Continuous Child Glucose Outcomes · plain
“Maternal 1-h and 2-h PG during the pregnancy OGTT and maternal sum of glucose z scores were positively associated with all child glucose measures and A1C in all models”
Quote in the paperSubstantial claim - Also stated in: § Associations Between Continuous Maternal Glycemia and Continuous Child Glucose Outcomes · plain
- Findingown data
Across increasing categories of maternal glucose, timed plasma glucose measures and A1C were higher.
“Across increasing categories of maternal glucose, frequencies of child IFG and IGT, and timed PG measures and A1C were higher, whereas insulin sensitivity and disposition index decreased.”
Quote in the paperSubstantial claim - Findingown data
Maternal 1-h plasma glucose during pregnancy is positively associated with child A1C.
“Maternal 1-h and 2-h PG were positively associated with child fasting, 30 min, 1-h, and 2-h PG, and A1C.”
- Also stated in: § Associations Between Continuous Maternal Glycemia and Continuous Child Glucose Outcomes · plain
“Maternal 1-h and 2-h PG during the pregnancy OGTT and maternal sum of glucose z scores were positively associated with all child glucose measures and A1C in all models”
Quote in the paperSubstantial claim - Also stated in: § Associations Between Continuous Maternal Glycemia and Continuous Child Glucose Outcomes · plain
- Findingown data
Interaction terms between maternal glucose levels and Tanner stage were not statistically significant for child IFG and IGT.
“Interaction terms between maternal glucose levels and Tanner stage were not statistically significant, but exploratory analyses within Tanner stage again suggested associations may be strongest for IGT after onset of puberty (Supplementary Table 4).”
Quote in the paperNot a substantial claim - Findingown data
Maternal 1-h plasma glucose during pregnancy is positively associated with child 1-h plasma glucose.
“Maternal 1-h and 2-h PG were positively associated with child fasting, 30 min, 1-h, and 2-h PG, and A1C.”
- Also stated in: § Associations Between Continuous Maternal Glycemia and Continuous Child Glucose Outcomes · plain
“Maternal 1-h and 2-h PG during the pregnancy OGTT and maternal sum of glucose z scores were positively associated with all child glucose measures and A1C in all models”
Quote in the paperSubstantial claim - Also stated in: § Associations Between Continuous Maternal Glycemia and Continuous Child Glucose Outcomes · plain
- Findingown data
Maternal 1-h plasma glucose during pregnancy is associated with child impaired glucose tolerance.
“Maternal FPG, but not 1-h or 2-h PG, was associated with child IFG, and maternal 1-h and 2-h PG, but not FPG, were associated with child IGT.”
Quote in the paperSubstantial claim - Findingown data
Child insulin sensitivity and disposition index decreased across categories of maternal fasting, 1-h, and 2-h plasma glucose during the pregnancy OGTT.
“Child insulin sensitivity and disposition index decreased across categories of maternal fasting, 1-h, and 2-h PG during the pregnancy OGTT (Fig. 2).”
Quote in the paperSubstantial claim - Findingown data
All categories of maternal fasting plasma glucose were significantly associated with child IFG in the fully adjusted model 4.
“All categories of maternal FPG were significantly associated with child IFG in the fully adjusted model (model 4).”
Quote in the paperSubstantial claim - Findingown data
Maternal 1-h plasma glucose during pregnancy is inversely associated with child insulin sensitivity.
“Maternal FPG, 1-h, and 2-h PG were inversely associated with insulin sensitivity, whereas 1-h and 2-h PG were inversely associated with disposition index.”
Quote in the paperSubstantial claim - Findingown data
Adjustment for maternal BMI and/or child BMI z score did not weaken the observed associations between maternal glucose and child IFG or IGT.
“Adjustment for maternal BMI and/or child BMI z score did not attenuate observed associations.”
Quote in the paperSubstantial claim - Findingown data
The frequency of child IFG increased across maternal glucose categories, with a doubling from the lowest to the highest maternal fasting glucose category (4.9% vs. 10.5%).
“The frequency of child IFG increased, in general, across maternal glucose categories with a doubling in frequency across the lowest and highest categories of maternal FPG (4.9% vs. 10.5%) (Fig. 2 and Supplementary Table 7).”
Quote in the paperSubstantial claim - Findingown data
Differences in group means adjusted for model 1 through 4 covariates confirmed linear trends across maternal glucose categories for child glucose measures.
“Differences in group means adjusted for model 1–4 covariates confirmed linear trends (Fig. 1 and Supplementary Table 5).”
Quote in the paperSubstantial claim - Findingown data
Maternal fasting plasma glucose was not associated with child IGT.
“In contrast, maternal FPG was not associated with child IGT”
Quote in the paperSubstantial claim - Findingown data
Maternal 2-h plasma glucose during pregnancy is positively associated with child 30-min plasma glucose.
“Maternal 1-h and 2-h PG were positively associated with child fasting, 30 min, 1-h, and 2-h PG, and A1C.”
- Also stated in: § Associations Between Continuous Maternal Glycemia and Continuous Child Glucose Outcomes · plain
“Maternal 1-h and 2-h PG during the pregnancy OGTT and maternal sum of glucose z scores were positively associated with all child glucose measures and A1C in all models”
Quote in the paperSubstantial claim - Also stated in: § Associations Between Continuous Maternal Glycemia and Continuous Child Glucose Outcomes · plain
- Findingown data
There was no clear pattern for the child insulinogenic index across maternal glucose categories.
“There was no clear pattern for child insulinogenic index across maternal glucose categories.”
Quote in the paperNot a substantial claim - Findingown data
Maternal fasting plasma glucose during pregnancy is positively associated with child fasting plasma glucose.
“Maternal fasting plasma glucose (FPG) was positively associated with child FPG and A1C”
- Also stated in: § Associations Between Continuous Maternal Glycemia and Continuous Child Glucose Outcomes · plain
“Maternal FPG was positively associated with child FPG, 30-min PG, the sum of glucose z scores, and A1C.”
Quote in the paperSubstantial claim - Also stated in: § Associations Between Continuous Maternal Glycemia and Continuous Child Glucose Outcomes · plain
- Findingown data
Maternal 2-h plasma glucose during pregnancy is inversely associated with child insulin sensitivity.
“Maternal FPG, 1-h, and 2-h PG were inversely associated with insulin sensitivity, whereas 1-h and 2-h PG were inversely associated with disposition index.”
Quote in the paperSubstantial claim - Findingown data
Maternal fasting plasma glucose was not associated with the child insulinogenic index after adjustment for maternal BMI and/or child BMI z score in models 2 through 4.
“Regarding child insulin secretion, maternal FPG was not associated with the insulinogenic index after adjusting for maternal BMI and/or child BMI z score (models 2–4).”
Quote in the paperNot a substantial claim - Findingown data
Maternal 1-h and 2-h plasma glucose and the sum of glucose z scores had a continuous inverse relationship with child insulin sensitivity and disposition index.
“Maternal 1-h and 2-h PG and the sum of glucose z scores also exhibited a continuous inverse relationship with child insulin sensitivity and disposition index.”
Quote in the paperSubstantial claim - Findingown data
Maternal 1-h plasma glucose levels were not associated with child IFG.
“Maternal 1-h PG levels were not associated with child IFG.”
Quote in the paperNot a substantial claim - Findingnone given
The association of maternal glucose levels with child glucose outcomes was most evident for insulin sensitivity and disposition index compared with insulin secretion.
“The association of maternal glucose levels with child glucose outcomes was most evident for insulin sensitivity and disposition index compared with insulin secretion.”
Quote in the paperSubstantial claim - Findingown data
For maternal 1-h plasma glucose, the three highest categories differed significantly from the lowest reference category for child IGT.
“For maternal 1-h PG, the three highest categories of maternal 1-h PG were significantly different from the lowest reference category (Supplementary Table 7).”
Quote in the paperSubstantial claim - Findingown data
The highest categories of maternal fasting and 2-h plasma glucose showed significant differences from the lowest reference categories for child IGT.
“The highest categories of maternal FPG and 2-h PG demonstrated significant differences relative to the lowest reference categories.”
Quote in the paperSubstantial claim - Findingown data
The highest category of maternal 2-h plasma glucose was not significantly different from the reference category for child IFG.
“The highest category of maternal 2-h PG was not significantly different from the reference category.”
Quote in the paperNot a substantial claim - Findingown data
Associations of maternal glucose with child glucose outcomes were independent of the child's family history of diabetes.
“Associations of maternal glucose with child glucose outcomes were also independent of the child’s family history of diabetes”
Quote in the paperSubstantial claim - Findingown data
Estimated maternal glucose response classes were associated with child IGT, with odds ratios of 1.81 (1.23-2.68) for class B versus A and 2.24 (1.25-4.01) for class C versus A after adjustment for model 4 covariates.
“Estimated glucose response classes demonstrated associations with child IGT with ORs (95% CI) of 1.81 (1.23–2.68, P = 0.0026) for class B versus A and 2.24 (1.25–4.01, P = 0.0065) for class C versus A, after adjustment for model 4 covariates.”
Quote in the paperSubstantial claim - Findingown data
Maternal 1-h and 2-h plasma glucose, A1C, and the sum of glucose z scores had a positive relationship with child IGT and glucose levels during the child OGTT.
“and of maternal 1-h and 2-h PG, A1C, and the sum of glucose z scores with child IGT and glucose levels during the child OGTT.”
Quote in the paperSubstantial claim - Findingown data
Trajectory classes were not associated with child IFG.
“Trajectory classes were not associated with child IFG.”
Quote in the paperNot a substantial claim - Findingown data
Class A was the largest trajectory class, comprising 87.8% (3,652 of 4,160) of HAPO maternal OGTTs.
“The largest class, class A, included 87.8% (3,652 of 4,160) of HAPO maternal OGTTs and reflects normal glucose tolerance.”
Quote in the paperNot a substantial claim - Premisecitation
HAPO demonstrated that the relationship between maternal glucose during pregnancy and newborn outcomes, including birth weight, sum of skinfolds, and cord C-peptide greater than the 90th percentile, was progressively higher across increasing categories of maternal glucose at 28 weeks of gestation.
“HAPO also demonstrated that the relationship between maternal glucose during pregnancy and newborn outcomes, including birth weight, sum of skinfolds, and cord C-peptide greater than the 90th percentile, was progressively higher across increasing categories of maternal glucose at 28 weeks of gestation.”
Quote in the paperSubstantial claim - Interpretationown data
Across the maternal glucose spectrum, higher in utero exposure is significantly associated with childhood glucose and insulin resistance independent of maternal and childhood BMI and family history of diabetes.
“Across the maternal glucose spectrum, exposure to higher levels in utero is significantly associated with childhood glucose and insulin resistance independent of maternal and childhood BMI and family history of diabetes.”
Quote in the paperSubstantial claim - Study design and conductown data
C statistics and R2 values changed little across models 1-4, indicating detected associations varied little across covariate adjustments.
“C statistics and R2 values changed little for each outcome for models 1–4, indicating that detected associations varied little across covariate adjustments.”
Quote in the paperNot a substantial claim - Premisecitation
Prior animal and human studies have shown that intrauterine exposure to maternal preexisting diabetes or gestational diabetes is associated with higher risk for altered offspring glucose metabolism.
“animal and human studies have shown that intrauterine exposure to maternal preexisting diabetes or gestational diabetes mellitus (GDM) is associated with higher risk for altered offspring glucose metabolism (7–11).”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [7] Metzger, 2007, Long-term outcomes in mothers diagnosed with gestational diabetes mellitus and their offspring, Clin Obstet Gynecol source
Not checked in the free run.
- cites [8] Pettitt, 1988, Congenital susceptibility to NIDDM. Role of intrauterine environment, Diabetes source
Not checked in the free run.
- cites [9] Silverman, 1998, Long-term effects of the intrauterine environment, Diabetes Care
Not checked in the free run.
- cites [10] Franks, 2006, Gestational glucose tolerance and risk of type 2 diabetes in young Pima Indian offspring, Diabetes source
Not checked in the free run.
- cites [11] Lowe, 2019, HAPO Follow-up Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): maternal gestational diabetes mellitus and childhood glucose metabolism, Diabetes Care source
Not checked in the free run.
- Study design and conductnone given
The HAPO FUS cohort was not confounded by treatment during pregnancy.
“The HAPO Follow-up Study (FUS) offered a unique opportunity to examine this question in a cohort not confounded by treatment during pregnancy.”
Quote in the paperSubstantial claim - Study design and conductcitation
Findings varied little under a missing-not-at-random assumption.
“A “missing at random” assumption was used after confirming findings varied little under “missing not at random” (14).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [14] Lowe, 2018, Association of gestational diabetes with maternal disorders of glucose metabolism and childhood adiposity, JAMA source
Not checked in the free run.
- The authors state this as an assumption: Missing Tanner stage data were missing at random.
- Premisecitation
A recent analysis of glucose levels during an OGTT in nonpregnant adults identified trajectory classes similar to the three classes identified in this study.
“A recent analysis of glucose levels during an OGTT in nonpregnant adults identified groups with trajectory classes similar to the three classes identified here (39).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [39] Hulman, 2018, Pathophysiological characteristics underlying different glucose response curves: a latent class trajectory analysis from the prospective EGIR-RISC study, Diabetes Care source
Not checked in the free run.
- Interpretationreasoning
These data are consistent with the higher risk for IGT in offspring of women in classes B and C observed in the current study.
“These data are consistent with the higher risk for IGT in offspring of women in classes B and C observed in the current study.”
Quote in the paperSubstantial claim - Premisecitation
Children and adults with a low disposition index are most likely to progress to type 2 diabetes.
“whereas children and adults with a low disposition index are most likely to progress to type 2 diabetes (19,34–38).”
Quote in the paperSubstantial claim0 of 6 sources checked- cites [19] American Diabetes Association, 2017, Classification and diagnosis of diabetes, Diabetes Care source
Not checked in the free run.
- cites [34] Abdul-Ghani, 2007, What is the best predictor of future type 2 diabetes, Diabetes Care source
Not checked in the free run.
- cites [35] Holder, 2014, A low disposition index in adolescent offspring of mothers with gestational diabetes: a risk marker for the development of impaired glucose tolerance in youth, Diabetologia source
Not checked in the free run.
- cites [36] Lorenzo, 2010, Disposition index, glucose effectiveness, and conversion to type 2 diabetes: the Insulin Resistance Atherosclerosis Study (IRAS), Diabetes Care source
Not checked in the free run.
- cites [37] Cali, 2009, Primary defects in beta-cell function further exacerbated by worsening of insulin resistance mark the development of impaired glucose tolerance in obese adolescents, Diabetes Care source
Not checked in the free run.
- cites [38] Utzschneider, 2009, Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels, Diabetes Care source
Not checked in the free run.
- Study design and conductnone given
HAPO included mothers with glucose values during pregnancy across the spectrum of maternal glycemia lower than those diagnostic of diabetes.
“Second, HAPO included mothers with glucose values during pregnancy across the spectrum of maternal glycemia lower than those diagnostic of diabetes.”
Quote in the paperSubstantial claim - Interpretationreasoning
Children exposed in utero to higher glucose levels may be at higher risk for progression to type 2 diabetes over time.
“Thus, children exposed in utero to higher levels of glucose may be at higher risk for progression to type 2 diabetes over time.”
Quote in the paperSubstantial claim - Interpretationown data
Class A reflects normal glucose tolerance.
“The largest class, class A, included 87.8% (3,652 of 4,160) of HAPO maternal OGTTs and reflects normal glucose tolerance.”
Quote in the paperSubstantial claim - Interpretationreasoning
Beyond shared genetics and postnatal environmental factors, the data are consistent with a potential contribution of fetal programming.
“Beyond the contributions of shared genetics and postnatal environmental factors, the data are also consistent with a potential contribution of fetal programming.”
Quote in the paperSubstantial claim - Study design and conductown data
The proportion of participants who met IADPSG GDM criteria and participated in HAPO FUS (weighted estimate 14.9%) is lower than in all eligible participants (16.2%).
“First, the proportion of participants who met IADPSG GDM criteria and participated in the HAPO FUS (weighted estimate 14.9%) is lower than in all eligible participants (16.2%).”
Quote in the paperNot a substantial claim - Interpretationreasoning
The inverse association of maternal glucose levels with the child disposition index represents inadequate β-cell compensation for insulin resistance in children exposed to higher glucose levels in utero.
“The inverse association of maternal glucose levels with the child disposition index represents inadequate β-cell compensation for the insulin resistance in children exposed to higher levels of glucose in utero.”
Quote in the paperSubstantial claim - Interpretationreasoning
The associations of maternal fasting glucose with child fasting glucose and IFG and of maternal 1-h and 2-h glucose with child IGT suggest that shared genetics not captured by family history may have contributed to the associations.
“although the associations of maternal FPG with child FPG and IFG and maternal 1-h and 2-h PG with child IGT suggest that shared genetics not captured by family history may have contributed to the associations.”
Quote in the paperSubstantial claim - Study design and conductown data
Some participants could not have IGT completely diagnosed because of missing 2-h plasma glucose measurements.
“Second, we were unable to completely diagnose IGT in all participants because of some missing 2-h PG measurements.”
Quote in the paperNot a substantial claim - Interpretationown data
The relationship between maternal glucose levels during pregnancy and child glucose levels and related outcomes was generally linear across the glucose spectrum, including levels below those used to diagnose GDM.
“The current study demonstrates that the relationship between maternal glucose levels during pregnancy and child glucose levels and related outcomes was generally linear across the spectrum of glucose levels, including levels below those diagnostic of GDM.”
Quote in the paperSubstantial claim - Premisecitation
In children, insulin resistance is an early finding in those with abnormal glucose metabolism.
“In children, insulin resistance is an early finding in those with abnormal glucose metabolism (33)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [33] Chen, 2018, Comparison of β-cell function between overweight/obese adults and adolescents across the spectrum of glycemia, Diabetes Care source
Not checked in the free run.
- Study design and conductnone given
Participants with fasting and/or 2-h OGTT plasma glucose values during the HAPO pregnancy above predefined thresholds were unblinded during HAPO and excluded from HAPO FUS.
“Third, participants with fasting and/or 2-h OGTT PG values during the HAPO pregnancy that were above predefined thresholds were unblinded during HAPO and excluded from the HAPO FUS.”
Quote in the paperSubstantial claim - Interpretationreasoning
These findings suggest that maternal glycemia may also contribute to the increasing prevalence of type 2 diabetes in children.
“Although the underlying causes for the increasing prevalence of type 2 diabetes in children are complex, these findings suggest that maternal glycemia may also contribute.”
Quote in the paperSubstantial claim
- May combine two claims. 28
- Classified as probably not a substantial claim. 19
May combine two claims.
Findingown dataAdjustment for maternal BMI or child BMI z score weakened the associations between maternal glucose measures and child Matsuda index, but those associations remained statistically significant.
“Adjusting for maternal BMI or child BMI z score in models 2–4 attenuated associations with the Matsuda index, but all associations remained significant.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataNeither maternal 1-h nor 2-h plasma glucose was associated with child IFG.
“Neither maternal 1-h nor 2-h PG was associated with child IFG.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataExploratory analyses within Tanner stage suggested that some associations may be strongest after the onset of puberty.
“exploratory analyses within the Tanner stage suggested some associations may be strongest after onset of puberty (Supplementary Table 3).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn the HAPO FUS cohort, higher continuous maternal fasting, 1-h, and 2-h plasma glucose and higher sum of glucose z scores during pregnancy were each associated with a lower child Matsuda index, indicating greater child insulin resistance.
“Regarding child insulin resistance, continuous maternal FPG, 1-h and 2-h PG, and the sum of glucose z scores were inversely associated with child Matsuda index (i.e., associated with greater insulin resistance) (Table 1).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataExploratory analyses within Tanner stage suggested that associations with IGT may be strongest after the onset of puberty.
“but exploratory analyses within Tanner stage again suggested associations may be strongest for IGT after onset of puberty (Supplementary Table 4).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataMaternal fasting plasma glucose and the sum of glucose z scores during pregnancy were associated with child IFG.
“Maternal FPG and maternal sum of glucose z scores during pregnancy were associated with child IFG.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataMothers of children who participated and those who did not had mean ages and gestational diabetes frequencies of 30.0 years and 14.9% versus 29.1 years and 16.9%, respectively.
“The mean age and frequency of GDM were 30.0 years and 14.9% and 29.1 years and 16.9% in mothers of children who did and did not participate, respectively.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S1 (asserted).
Findingown dataMaternal fasting plasma glucose during pregnancy is not associated with child impaired glucose tolerance.
“Maternal FPG, but not 1-h or 2-h PG, was associated with child IFG, and maternal 1-h and 2-h PG, but not FPG, were associated with child IGT.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataMean BMI, fasting plasma glucose, 1-h, and 2-h plasma glucose during the HAPO OGTT and race/ethnicity were similar between participants and nonparticipants.
“Mean BMI, FPG, 1-h, and 2-h PG during the HAPO OGTT and race/ethnicity were similar between groups.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAdjustment for maternal BMI and/or child BMI z score did not weaken associations of maternal glucose with child glucose outcomes, except for insulin sensitivity, which remained significant after adjustment.
“However, adjustment for maternal BMI and/or child BMI z score did not attenuate associations of maternal glucose levels with child glucose outcomes, except for insulin sensitivity, although this association also remained significant after adjustment.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataClass C comprised 3.2% (132 of 4,160) of HAPO OGTTs and was characterized by high 1-h plasma glucose and a marked decline at 2 h.
“Class C included 3.2% (132 of 4,160) of HAPO OGTTs with high 1-h PG and marked decline at 2-h.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataTrajectory analyses indicated that the best-fitting model used quadratic trajectories adjusted for maternal BMI at the OGTT and estimated three latent classes.
“Analyses indicated best fit of quadratic trajectories adjusted for maternal BMI at OGTT with three estimated latent classes (Fig. 3).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataClass B comprised 9.0% (376 of 4,160) of HAPO OGTTs and was characterized by high 1-h and 2-h plasma glucose values.
“A second class, class B, included 9.0% (376 of 4,160) of HAPO OGTTs with high 1-h and 2-h PG values.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe current study demonstrates that maternal glucose levels during pregnancy across the spectrum are associated with higher glucose levels and insulin resistance during childhood independent of maternal and child BMI and family history of diabetes, and that this relationship is continuous.
“In summary, the current study demonstrates that maternal glucose levels during pregnancy across the spectrum are associated with higher glucose levels and insulin resistance during childhood independent of maternal and child BMI and family history of diabetes and that this relationship is continuous.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataMaternal fasting plasma glucose and the sum of glucose z scores during the pregnancy OGTT had a positive relationship with child fasting plasma glucose and IFG.
“This included a positive relationship of maternal FPG and the sum of glucose z scores during the pregnancy OGTT with child FPG and IFG”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe frequency of child IGT was higher across increasing categories of maternal glucose, consistent with linear associations confirmed in logistic regression models.
“The frequency of child IGT was higher across increasing categories of maternal glucose, consistent with the linear associations confirmed in logistic regression models (Fig. 2).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataFor maternal 2-h plasma glucose, the middle three categories differed significantly from the lowest reference category with similar odds ratios for child IFG.
“For maternal 2-h PG, the middle three categories were significantly different from the lowest reference category with similar odds ratios (ORs).”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationA prior HAPO FUS analysis demonstrated an inverse association of gestational diabetes by IADPSG criteria with insulin sensitivity and disposition index and a positive association with impaired glucose tolerance in children ages 10-14 years.
“We recently demonstrated an inverse association of GDM, using IADPSG criteria, with insulin sensitivity and the disposition index and positive association with impaired glucose tolerance (IGT) in HAPO FUS children at ages 10–14 years (11).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [11] Lowe, 2019, HAPO Follow-up Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): maternal gestational diabetes mellitus and childhood glucose metabolism, Diabetes Care source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationThe recruitment target was 7,000 mother-child pairs, based on the primary childhood outcome of overweight/obesity.
“The recruitment target was 7,000 pairs, based on the primary childhood outcome of overweight/obesity (14).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [14] Lowe, 2018, Association of gestational diabetes with maternal disorders of glucose metabolism and childhood adiposity, JAMA source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataColinearity was not a concern, with pairwise correlations ranging from 0 to 0.20 for model covariates.
“Colinearity was not a concern, with pairwise correlations ranging from 0 to 0.20 for model covariates.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataHosmer-Lemeshow P values ranged 0.53-0.96 for all outcomes, indicating reasonable model fit.
“Hosmer-Lemeshow P values for logistic regression models ranged 0.53–0.96 for all outcomes, indicating reasonable model fit.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataDFBETA statistics indicated no observations of undue influence.
“DFBETA statistics indicated no observations of undue influence.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataMean coefficients of variation for C-peptide measurements ranged from 2.8% to 3.2%.
“Mean CVs were 2.8% for fasting, 2.9% for 30-min, 3.0% for 1-h, and 3.2% for 2-h C-peptide.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown dataResidual plots indicated reasonable linearity, and P values for quadratic terms and restricted cubic splines ranged 0.05-0.99, indicating no significant departure from linearity.
“Residual plots indicated reasonable linearity. Confirming this, P values for quadratic terms and restricted cubic splines ranged 0.05–0.99, indicating no significant departure from linearity for all analyses.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenBlinded participants were untreated.
“Blinded participants were untreated.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenBlinded duplicate samples were assayed several weeks apart.
“Blinded duplicate samples were assayed several weeks apart.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationHAPO OGTT results were blinded to caregivers and participants except under specified criteria.
“OGTT results remained blinded to caregivers and participants unless FPG >5.8 mmol/L and/or 2-h PG >11.1 mmol/L, either was <2.5 mmol/L, or random PG at 34–37 weeks of gestation was ≥8.9 mmol/L (12).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [12] Metzger, 2008, Hyperglycemia and adverse pregnancy outcomes, N Engl J Med source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataC statistics for logistic regression models ranged 0.69-0.78, and R2 values ranged 0.05-0.39 for linear models.
“C statistics for logistic regression models ranged 0.69–0.78, and R2 values ranged 0.05–0.39 for linear models.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataMean coefficients of variation for glucose and A1C measurements were low: 1.5% for fasting, 1-h, and 2-h plasma glucose, 1.3% for 30-min plasma glucose, and 3.1% for A1C.
“mean CV was 1.5% for fasting, 1-h, and 2-h PG, 1.3% for 30-min PG, and 3.1% for A1C.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe study was not powered to evaluate Tanner stage-specific associations.
“Although the study was not powered to evaluate Tanner stage–specific associations, interaction terms between maternal glucose measures and Tanner stage were evaluated to explore potential variability in associations according to pubertal status.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoning427 participants (1.8%) had OGTT results unblinded based on fasting and/or 2-h plasma glucose.
“Using these criteria, the results of 427 participants (1.8%) were unblinded based on FPG and/or 2-h PG.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataThe long-term type 2 diabetes risk associated with a pattern similar to class C and the risk for child IGT with high 1-h plasma glucose observed in the current study demonstrate the importance of maternal 1-h glucose level separate from other values and provide a rationale for its inclusion during the pregnancy OGTT.
“The long-term type 2 diabetes risk associated with a pattern similar to class C and risk for child IGT with high 1-h PG observed in the current study demonstrate the importance of the maternal 1-h glucose level separate from other values and provide a rationale for its inclusion during the pregnancy OGTT.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductreasoningThe HAPO and HAPO FUS cohorts included participants from multiple races and ethnicities around the world, making the results broadly applicable.
“Third, the HAPO and HAPO FUS cohorts included participants from multiple races and ethnicities around the world, making the results broadly applicable.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenPaternal BMI data were not available, and paternal diabetes data were limited to family history.
“Fourth, paternal BMI data were not available, and paternal diabetes data were limited to family history.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationA second study of nonpregnant adults showed that those with a curve similar to class C had a higher risk of future type 2 diabetes compared with class A, while those with a curve similar to class B had an even higher risk of type 2 diabetes and future cardiovascular disease.
“A second study of nonpregnant adults showed that those with a curve similar to class C had a higher risk of future type 2 diabetes compared with those with a curve similar to class A (40), whereas those with a curve similar to class B had an even higher risk of type 2 diabetes as well as future cardiovascular disease.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [40] Hulman, 2018, Glucose patterns during an oral glucose tolerance test and associations with future diabetes, cardiovascular disease and all-cause mortality rate, Diabetologia source
Not checked in the free run.
May combine two claims.
Interpretationown dataAlthough the confidence intervals for classes B and C relative to class A overlapped, the odds ratio estimates suggested a possible trend of higher IGT risk for children whose mothers had class C trajectories.
“Although the CIs for classes B and C relative to class A overlapped, OR estimates indicated a possible trend of higher risk of IGT for children with maternal pregnancy OGTT trajectories in class C.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductreasoningHAPO was a blinded observational study in which caregivers and mothers were unaware of maternal glucose levels, so child outcomes were not confounded by treatment of maternal hyperglycemia.
“First, HAPO was a blinded observational study in which both caregivers and mothers were not aware of maternal glucose levels, and thus, child outcomes were not confounded by treatment of maternal hyperglycemia.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe study was not powered to examine Tanner stage-specific associations.
“Finally, the study was not powered to examine Tanner stage–specific associations.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn nonpregnant adults, individuals with a curve similar to class B were most insulin resistant and had impaired insulin secretion.
“Individuals with a curve similar to class B were most insulin resistant and had impaired insulin secretion.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [39] Hulman, 2018, Pathophysiological characteristics underlying different glucose response curves: a latent class trajectory analysis from the prospective EGIR-RISC study, Diabetes Care source
Not checked in the free run.
May combine two claims.
Study design and conductreasoningParticipants missing a 2-h plasma glucose value who had normal fasting plasma glucose were defined as normal, so the number of individuals with IGT may have been underestimated.
“Participants missing a 2-h PG value who had a normal FPG were defined as normal; thus, the number of individuals with IGT may have been underestimated.”
Quote in the paperNot a substantial claim- Rests on an assumption: Participants missing a 2-h plasma glucose value who had normal fasting plasma glucose are normal with respect to IGT status.
May combine two claims.
PremisecitationChild adiposity is partly dependent on maternal adiposity and affects insulin sensitivity and glucose metabolism.
“Child adiposity, which is partly dependent on maternal adiposity (28,29), affects insulin sensitivity and glucose metabolism (30).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [28] Philipps, 2011, The diabetic pregnancy and offspring BMI in childhood: a systematic review and meta-analysis, Diabetologia source
Not checked in the free run.
- cites [29] Zhao, 2016, Maternal gestational diabetes and childhood obesity at age 9-11: results of a multinational study, Diabetologia source
Not checked in the free run.
- cites [30] Weiss, 2008, Metabolic complications of childhood obesity: identifying and mitigating the risk, Diabetes Care source
Not checked in the free run.
May combine two claims.
PremisecitationIn nonpregnant adults, individuals with curves similar to class C had lower first-phase insulin secretion and insulin sensitivity but greater overall insulin secretion.
“Individuals with curves similar to class C had lower first-phase insulin secretion and insulin sensitivity but greater insulin secretion overall.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [39] Hulman, 2018, Pathophysiological characteristics underlying different glucose response curves: a latent class trajectory analysis from the prospective EGIR-RISC study, Diabetes Care source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThe excluded subgroup, 1.8% of the HAPO cohort, would likely include children at highest risk of altered glucose metabolism.
“This subgroup (1.8% of the HAPO cohort) would likely include children at highest risk of altered glucose metabolism.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
The relationship between maternal glucose levels across the spectrum and childhood glucose metabolism was not known before this study.
“However, the relationship between maternal glucose levels across the spectrum of glucose values and childhood glucose metabolism is not known.”
“Whether similar relationships exist between maternal glucose levels during pregnancy across the continuum and childhood metabolic outcomes is unknown.”
The authors state this as an assumption.
Missing Tanner stage data were missing at random.
“A “missing at random” assumption was used after confirming findings varied little under “missing not at random” (14).”
The paper relies on this without support.
Participants missing a 2-h plasma glucose value who had normal fasting plasma glucose are normal with respect to IGT status.
“Participants missing a 2-h PG value who had a normal FPG were defined as normal; thus, the number of individuals with IGT may have been underestimated.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Offspring glucose levels from the 75 g oral glucose tolerance test and glycosylated hemoglobin were linearly associated with maternal glucose levels during pregnancy independent of maternal and child BMI.
“Consistent with obesity parameters, offspring glucose levels from the 75 g OGTT and glycosylated hemoglobin were linearly associated with maternal glucose levels during pregnancy independent of maternal and child BMI [34,35].”
From Gestational Diabetes Mellitus: Diagnostic Approaches and Maternal-Offspring Complications (2022) · cites this paper as [35]
The Results sections on continuous and categorical outcomes report generally linear associations between maternal pregnancy glucose and child glucose and A1C, persisting after adjustment for maternal BMI and child BMI z score. The Study Visit section specifies that children received 1.75 g/kg of glucose, capped at 75 g—not uniformly a 75 g dose. The associations also varied by measure: maternal fasting glucose was not associated with child 1-hour or 2-hour glucose. (LLM, conf=0.86)
Experimental — accuracy not yet measuredGDM is characterized by an increased risk of large-for-gestational-age birth weight and neonatal and pregnancy complications and an increased risk of long-term maternal type 2 diabetes and abnormal glucose metabolism of offspring in childhood.
“GDM is characterized by an increased risk of large-for-gestational-age birth weight and neonatal and pregnancy complications and an increased risk of long-term maternal type 2 diabetes and abnormal glucose metabolism of offspring in childhood.”
From 15. Management of Diabetes in Pregnancy: <i>Standards of Care in Diabetes—2024</i> (2024) · cites this paper as [56]
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measuredPost hoc GDM in individuals diagnosed with the one-step method in the HAPO cohort was associated with higher prevalence of IGT; higher 30-min, 1-h, and 2-h glucose levels during the OGTT; and reduced insulin sensitivity and oral disposition index in their offspring at 10-14 years of age compared with offspring of mothers without GDM.
“Post hoc GDM in individuals diagnosed with this method in the HAPO cohort was associated with higher prevalence of IGT; higher 30-min, 1-h, and 2-h glucose levels during the OGTT; and reduced insulin sensitivity and oral disposition index in their offspring at 10-14 years of age compared with offspring of mothers without GDM.”
From 2. Diagnosis and classification of diabetes: standards of care in diabetes-2025 (2025) · cites this paper as [199]
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measuredAssociations of mother's fasting, 1-h, and 2-h values on the 75-g OGTT were continuous with a comprehensive panel of offspring metabolic outcomes.
“Associations of mother's fasting, 1-h, and 2-h values on the 75-g OGTT were continuous with a comprehensive panel of offspring metabolic outcomes (198,199).”
From 2. Diagnosis and classification of diabetes: standards of care in diabetes-2025 (2025) · cites this paper as [199]
The Results section, under “Associations Between Continuous Maternal Glycemia and Continuous Child Glucose Outcomes,” examines maternal fasting, 1-h, and 2-h OGTT values against a broad panel of child outcomes. But the associations were not present for every value–outcome pair: maternal fasting glucose was not associated with child 1-h or 2-h glucose, and it was not significantly associated with disposition index. The cited passages provide no page numbers. (LLM, conf=0.85)
Experimental — accuracy not yet measuredHAPO-FUS found persistent metabolic consequences of maternal hyperglycemia on long-term offspring glucose homeostasis, extending to glycemic levels below current GDM diagnostic thresholds.
“Findings revealed persistent metabolic consequences of maternal hyperglycemia on long-term offspring glucose homeostasis, notably extending to glycemic levels below current GDM diagnostic thresholds.”
From Maternal Overnutrition and Fetal Programming: Long-Term Metabolic, Cognitive, and Epigenetic Consequences (2026) · cites this paper as [61]
The Results (Associations Between Categorical Maternal Glycemia and Child Glucose Outcomes; page unavailable) report a continuous relationship between maternal glucose and child glucose measures at ages 10–14, including maternal glucose categories below the GDM diagnostic thresholds. But the study reports associations, not established persistent metabolic consequences caused by maternal hyperglycemia; the Conclusions describe fetal programming only as a potential contribution. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Maternal glucose elevation has inverse associations with offspring insulin sensitivity and HOMA indices at 14 years, persisting after adjustment for maternal BMI, offspring BMI, and familial diabetes predisposition.
“Conversely, maternal glucose elevation demonstrated inverse associations with offspring insulin sensitivity and homeostatic model assessment (HOMA) indices at 14 years, with these relationships persisting after statistical adjustment for maternal body mass index, offspring BMI, and familial diabetes predisposition.”
From Maternal Overnutrition and Fetal Programming: Long-Term Metabolic, Cognitive, and Epigenetic Consequences (2026) · cites this paper as [61]
The Results (Associations Between Continuous Maternal Glycemia and Continuous Child Glucose Outcomes; page unavailable) report inverse associations with child insulin sensitivity that remained significant after BMI adjustment; the model notes include adjustment for first-degree family history of diabetes. However, the Calculations section identifies the indices as Matsuda, insulinogenic, and disposition—not HOMA—and the Methods describe children aged 10–14 years, not exclusively 14-year-olds. (LLM, conf=0.91)
Experimental — accuracy not yet measuredIncreased glucose-linked hypothalamic activation in offspring exposed to maternal obesity and GDM in utero is one possible mechanism for increased childhood obesity risk.
“Furthermore, recent evidence shows that there is increased glucose-linked hypothalamic activation in offspring who were previously exposed to maternal obesity and GDM in utero, which represents one possible mechanism for this increased childhood obesity risk [31,32,60,61].”
From Maternal Overnutrition and Fetal Programming: Long-Term Metabolic, Cognitive, and Epigenetic Consequences (2026) · cites this paper as [61]
The Conclusions report an association between higher maternal glucose levels and childhood obesity in a related HAPO FUS analysis, and describe fetal programming as a possibility (page not provided). They do not report glucose-linked hypothalamic activation or identify it as a mechanism, so the claim’s central mechanistic point is unsupported by this paper. (LLM, conf=0.84)
Experimental — accuracy not yet measuredAssociations of maternal OGTT results with outcomes are continuous with no clear inflection points.
“These associations with maternal oral glucose tolerance test (OGTT) results are continuous with no clear inflection points (39,56).”
From 15. Management of Diabetes in Pregnancy: <i>Standards of Care in Diabetes—2024</i> (2024) · cites this paper as [56]
Associations of mother's fasting, 1-h, and 2-h values on the 75-g OGTT were continuous with a comprehensive panel of offspring metabolic outcomes.
“Associations of mother ' s fasting, 1h, and 2-h values on the 75-g OGTT were continuous with a comprehensive panel of offspring metabolic outcomes (216, 217).”
From 2. Diagnosis and Classification of Diabetes: <i>Standards of Care in Diabetes—2024</i> (2024) · cites this paper as [217]
A dose-dependent relationship exists between maternal antenatal glycemia and offspring metabolic parameters across the continuum of glucose concentrations.
“A dose-dependent relationship emerged between maternal antenatal glycemia and offspring metabolic parameters across the continuum of glucose concentrations.”
From Maternal Overnutrition and Fetal Programming: Long-Term Metabolic, Cognitive, and Epigenetic Consequences (2026) · cites this paper as [61]
Maternal glycemic dysregulation correlates with increased prevalence of impaired fasting glucose, glucose intolerance, elevated glycated hemoglobin, and pediatric obesity in adolescent offspring.
“Maternal glycemic dysregulation correlated with increased prevalence of impaired fasting glucose, glucose intolerance, elevated glycated hemoglobin, and pediatric obesity in adolescent offspring.”
From Maternal Overnutrition and Fetal Programming: Long-Term Metabolic, Cognitive, and Epigenetic Consequences (2026) · cites this paper as [61]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Significant insulinogenic result has an interval crossing zero
MajorFor the model 4 maternal glucose-sum result, the reported P value is below 0.05, but its 95% confidence interval includes zero. These disagree on significance for the same estimate.
“−0.011 (−0.021 to 0.0012)”
“P = 0.031, R2 = 0.08”
Maternal 1-hour Matsuda estimate falls outside its reported interval
MinorThe model 2 interval endpoints have a midpoint of 22.4, whereas the reported coefficient is −67.1. That coefficient is outside the interval even if the endpoints are reordered.
Reported -67.1 · recomputed 22.4
“−67.1 (89.5 to −44.7) P < 0.001, R2 = 0.24”
Narrative omits a significant model 2 insulinogenic association
MinorThe text says the maternal 2-hour glucose association with the insulinogenic index appears only in models 3 and 4, but Table 1 also reports a significant model 2 result (P = 0.046).
“maternal 2-h PG was inversely associated with the insulinogenic index after adjusting for child BMI z score alone or together with maternal BMI (models 3 and 4).”
“−0.024 (−0.048 to −0.0059) P = 0.046, R2 = 0.06”
Glucose-sum insulinogenic estimate falls outside its interval
MinorThe model 3 coefficient is −0.089, outside its reported interval of −0.019 to 0.0012. The interval's midpoint is −0.0089.
Reported -0.089 · recomputed -0.0089
“−0.089 (−0.019 to 0.0012) P = 0.081, R2 = 0.08”
Maternal 1-hour insulinogenic estimate is inconsistent with its interval
MinorThe model 1 confidence interval is centered at −0.295, far from its reported coefficient of −0.034.
Reported -0.034 · recomputed -0.295
“−0.034 (−0.58 to −0.01) P < 0.001, R2 = 0.05”
Glucose-sum disposition interval has reversed bounds
MinorThe model 1 interval runs from −0.03 to −0.2, placing its reported coefficient of −0.02 outside both endpoints. Its endpoints also have a midpoint of −0.115.
Reported -0.02 · recomputed -0.115
“−0.02 (−0.03 to −0.2) P < 0.001, R2 = 0.08”
Cites
Nylund, K. L., Asparouhov, T., & Muthén, B. O. (2007) · Structural Equation Modeling: A Multidisciplinary Journal · doi:10.1080/10705510701575396 · Cited by 11,415 · see citing works
Abarca-Gómez, L., Abdeen, Z. A., Hamid, Z. A., Abu-Rmeileh, N. M., Acosta-Cazares, B., Acuin, C., Adams, R. J., Aekplakorn, W., Afsana, K., Aguilar-Salinas, C. A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32129-3 · Cited by 7,482 · see citing works
Self-citationMatsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621 · see citing works
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563 · see citing works
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390 · see citing works
Extended international ( IOTF ) body mass index cut‐offs for thinness, overweight and obesity
Cole, T. J., & Lobstein, T. (2012) · Pediatric Obesity · doi:10.1111/j.2047-6310.2012.00064.x · Cited by 3,135 · see citing works
Classification and Diagnosis of Diabetes
Fajans, S. S. (1990) · Medical Entomology and Zoology · Cited by 2,356 · see citing works
Metzger, B. E., Gabbe, S. G., Persson, B., Lowe, L. P., Dyer, A. R., Oats, J. J. N., & Buchanan, T. A. (2010) · Diabetes Care · doi:10.2337/dc10-0719 · Cited by 1,888 · see citing works
Self-citation2. Classification and Diagnosis of Diabetes
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc17-s005 · Cited by 1,603 · see citing works
Incidence trends of type 1 and type 2 diabetes among youths, 2002–2012
Mayer-Davis, E. J., Lawrence, J. M., Dabelea, D., Divers, J., Isom, S., Dolan, L., Imperatore, G., Linder, B., Marcovina, S., Pettitt, D. J., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1610187 · Cited by 1,476 · see citing works
Self-citationPrevalence of Type 1 and Type 2 Diabetes Among Children and Adolescents From 2001 to 2009
Dabelea, D., Mayer-Davis, E. J., Saydah, S., Imperatore, G., Linder, B., Divers, J., Bell, R., Badaru, A., Talton, J. W., Crume, T., et al. (2014) · JAMA · doi:10.1001/jama.2014.3201 · Cited by 1,412 · see citing works
Self-citationEstimation of Extended Mixed Models Using Latent Classes and Latent Processes: The R Package lcmm
Proust‐Lima, C., Philipps, V., & Liquet, B. (2017) · Journal of Statistical Software · doi:10.18637/jss.v078.i02 · Cited by 1,144 · see citing works
Estimation of extended mixed models using latent classes and latent processes: the R package lcmm
Proust‐Lima, C., Philipps, V., & Liquet, B. (2015) · RePEc: Research Papers in Economics · doi:10.48550/arxiv.1503.00890 · Cited by 764 · see citing works
Phillips, D. I. W., Clark, P. M., Hales, C. N., & Osmond, C. (1994) · Diabetic Medicine · doi:10.1111/j.1464-5491.1994.tb00273.x · Cited by 631 · see citing works
Lowe, W. L., Scholtens, D. M., Lowe, L. P., Kuang, A., Nodzenski, M., Talbot, O., Catalano, P. M., Linder, B., Brickman, W. J., Clayton, P., et al. (2018) · JAMA · doi:10.1001/jama.2018.11628 · Cited by 591 · see citing works
Self-citationEvaluating latent class analysis models in qualitative phenotype identification
Yang, C.-C. (2004) · Computational Statistics & Data Analysis · doi:10.1016/j.csda.2004.11.004 · Cited by 576 · see citing works
Lowe, W. L., Scholtens, D. M., Kuang, A., Linder, B., Lawrence, J. M., Lebenthal, Y., McCance, D., Hamilton, J., Nodzenski, M., Talbot, O., et al. (2019) · Diabetes Care · doi:10.2337/dc18-1646 · Cited by 574 · see citing works
Self-citationUtzschneider, K. M., Prigeon, R. L., Faulenbach, M. V., Tong, J., Carr, D. B., Boyko, E. J., Leonetti, D. L., McNeely, M. J., Fujimoto, W. Y., & Kahn, S. E. (2009) · Diabetes Care · doi:10.2337/dc08-1478 · Cited by 572 · see citing works
Congenital susceptibility to NIDDM. Role of intrauterine environment
Pettitt, D. J., Aleck, K. A., Baird, H. R., Carraher, M. J., Bennett, P. H., & Knowler, W. C. (1988) · Diabetes · doi:10.2337/diab.37.5.622 · Cited by 530 · see citing works
Hyperglycemia and Adverse Pregnancy Outcomes: The HAPO Study Cooperative Research Group
The HAPO Study Cooperative Research Group (2008) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e318187b7a2 · Cited by 488 · see citing works
(1998) · PubMed · Cited by 404 · see citing works
Self-citationYouth-Onset Type 2 Diabetes Consensus Report: Current Status, Challenges, and Priorities
Nadeau, K. J., Anderson, B. J., Berg, E. G., Chiang, J. L., Chou, H., Copeland, K. C., Hannon, T. S., Huang, T. T.-K., Lynch, J. L., Powell, J., et al. (2016) · Diabetes Care · doi:10.2337/dc16-1066 · Cited by 381 · see citing works
What is the best predictor of future type 2 diabetes
Abdul-Ghani, M. A., Williams, K., DeFronzo, R. A., & Stern, M. (2007) · Diabetes Care · doi:10.2337/dc06-1331 · Cited by 355 · see citing works
Long-term outcomes in mothers diagnosed with gestational diabetes mellitus and their offspring
METZGER, B. E. (2007) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0b013e31815a61d6 · Cited by 297 · see citing works
Self-citationon behalf of the HAPO Follow-up Study Cooperative Research Group, Lowe, W. L., Lowe, L. P., Kuang, A., Catalano, P. M., Nodzenski, M., Talbot, O., Tam, W.-H., Sacks, D. A., McCance, D., et al. (2019) · Diabetologia · doi:10.1007/s00125-018-4809-6 · Cited by 294 · see citing works
Self-citationGestational Glucose Tolerance and Risk of Type 2 Diabetes in Young Pima Indian Offspring
Franks, P. W., Looker, H. C., Kobes, S., Touger, L., Tataranni, P. A., Hanson, R. L., & Knowler, W. C. (2006) · Diabetes · doi:10.2337/diabetes.55.02.06.db05-0823 · Cited by 253 · see citing works
Metabolic Complications of Childhood Obesity
Weiss, R., & Kaufman, F. R. (2008) · Diabetes Care · doi:10.2337/dc08-s273 · Cited by 209 · see citing works
Viner, R., White, B., & Christie, D. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31371-5 · Cited by 195 · see citing works
The diabetic pregnancy and offspring BMI in childhood: a systematic review and meta-analysis
Philipps, L. H., Santhakumaran, S., Gale, C., Prior, E., Logan, K. M., Hyde, M. J., & Modi, N. (2011) · Diabetologia · doi:10.1007/s00125-011-2180-y · Cited by 182 · see citing works
Comparison of 11 Human Insulin Assays: Implications for Clinical Investigation and Research
Manley, S. E., STRATTON, I. M., CLARK, P. M. S., & Luzio, S. D. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.077784 · Cited by 172 · see citing works
Disposition Index, Glucose Effectiveness, and Conversion to Type 2 Diabetes
Lorenzo, C., Wagenknecht, L. E., Rewers, M. J., Karter, A. J., Bergman, R. N., Hanley, A. J. G., & Haffner, S. M. (2010) · Diabetes Care · doi:10.2337/dc10-0165 · Cited by 145 · see citing works
The changing face of diabetes in youth: lessons learned from studies of type 2 diabetes
Hannon, T. S., & Arslanian, S. A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12939 · Cited by 137 · see citing works
Cali, A. M. G., Man, C. D., Cobelli, C., Dziura, J., Seyal, A., Shaw, M., Allen, K., Chen, S., & Caprio, S. (2009) · Diabetes Care · doi:10.2337/dc08-1274 · Cited by 125 · see citing works
Maternal gestational diabetes and childhood obesity at age 9-11: results of a multinational study
for the ISCOLE Research Group, Zhao, P., Liu, E., Qiao, Y., Katzmarzyk, P. T., Chaput, J.-P., Fogelholm, M., Johnson, W. D., Kuriyan, R., Kurpad, A., et al. (2016) · Diabetologia · doi:10.1007/s00125-016-4062-9 · Cited by 122 · see citing works
Lacroix, M., Kina, E., & Hivert, M. (2013) · Current Diabetes Reports · doi:10.1007/s11892-012-0360-x · Cited by 78 · see citing works
Bush, N. C., Chandler-Laney, P. C., Rouse, D. J., Granger, W. M., Oster, R. A., & Gower, B. A. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2902 · Cited by 77 · see citing works
Jr Lowe, W. L., Scholtens, D. M., Lowe, L., Kuang, A., Nodzenski, M., Talbot, O., Catalano, P. M., Linder, B., Brickman, W. J., Clayton, P., et al. (2019) · Yearbook of pediatric endocrinology · doi:10.1530/ey.16.2.10 · Cited by 68 · see citing works
Self-citationHulman, A., Witte, D. R., Vistisen, D., Balkau, B., Dekker, J. M., Herder, C., Hatunic, M., Konrad, T., Færch, K., & Manco, M. (2018) · Diabetes Care · doi:10.2337/dc18-0279 · Cited by 66 · see citing works
Holder, T., Giannini, C., Santoro, N., Pierpont, B., Shaw, M., Duran, E., Caprio, S., & Weiss, R. (2014) · Diabetologia · doi:10.1007/s00125-014-3345-2 · Cited by 62 · see citing works
Hulman, A., Vistisen, D., Glümer, C., Bergman, M., Witte, D. R., & Færch, K. (2018) · Diabetologia · doi:10.1007/s00125-017-4468-z · Cited by 60 · see citing works
Weiss, R., Cali, A. M. G., Dziura, J. D., Burgert, T. S., Tamborlane, W. V., & Caprio, S. (2007) · Diabetes Care · doi:10.2337/dc07-0325 · Cited by 46 · see citing works
Chen, M. E., Chandramouli, A. G., Considine, R. V., Hannon, T. S., & Mather, K. J. (2018) · Diabetes Care · doi:10.2337/dc17-1373 · Cited by 26 · see citing works
Flagged first, then by citations
Research works printed but not linked: 2
- Silverman, 1998, Long-term effects of the intrauterine environment, Diabetes Care, 21, B142
- R Core Team, 2016, A Language and Environment for Statistical Computing
Cited by
Sorted by citations
2. Classification and Diagnosis of Diabetes: <i>Standards of Medical Care in Diabetes—2022</i>
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792 · see citing works
2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Gaglia, J. L., Hilliard, M. E., Isaacs, D. M., et al. (2022) · Diabetes Care · doi:10.2337/dc23-s002 · Cited by 2,652 · see citing works
2. Diagnosis and Classification of Diabetes: <i>Standards of Care in Diabetes—2024</i>
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s002 · Cited by 2,086 · see citing works
2. Diagnosis and classification of diabetes: standards of care in diabetes-2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Ebekozien, O., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s002 · Cited by 1,393 · see citing works
A Clinical Update on Gestational Diabetes Mellitus
Sweeting, A., Wong, J., Murphy, H. R., & Ross, G. P. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac003 · Cited by 928 · see citing works
15. Management of Diabetes in Pregnancy: <i>Standards of Medical Care in Diabetes—2022</i>
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s015 · Cited by 504 · see citing works
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s002 · Cited by 473 · see citing works
Gestational diabetes: opportunities for improving maternal and child health
Saravanan, P., Magee, L. A., Banerjee, A., Coleman, M. A., von Dadelszen, P., Denison, F. C., Farmer, A. A., Finer, S., Fox-Rushby, J. A., Holt, R. I. G., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30161-3 · Cited by 436 · see citing works
Self-citationGestational Diabetes Mellitus: Diagnostic Approaches and Maternal-Offspring Complications
Moon, J. H., & Jang, H. C. (2022) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0335 · Cited by 377 · see citing works
Gestational Diabetes Mellitus: A Harbinger of the Vicious Cycle of Diabetes
Alejandro, E. U., Mamerto, T. P., Chung, G., Villavieja, A., Gaus, N. L., Morgan, E., & Pineda-Cortel, M. R. B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145003 · Cited by 353 · see citing works
Prediction of gestational diabetes based on nationwide electronic health records
Artzi, N. S., Shilo, S., Hadar, E., Rossman, H., Barbash‐Hazan, S., Ben‐Haroush, A., Balicer, R. D., Feldman, B., Wiznitzer, A., & Segal, E. (2020) · Nature Medicine · doi:10.1038/s41591-019-0724-8 · Cited by 289 · see citing works
15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D. M., Johnson, E. L., et al. (2022) · Diabetes Care · doi:10.2337/dc23-s015 · Cited by 309 · see citing works
A pragmatic, randomized clinical trial of gestational diabetes screening
Hillier, T. A., Pedula, K. L., Ogasawara, K. K., Vesco, K. K., Oshiro, C. E. S., Lubarsky, S. L., & Van Marter, J. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2026028 · Cited by 270 · see citing works
14. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc21-s014 · Cited by 278 · see citing works
15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s015 · Cited by 252 · see citing works
Hyperglycemia During Pregnancy and Long-Term Offspring Outcomes
Bianco, M. E., & Josefson, J. L. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1267-6 · Cited by 253 · see citing works
Self-citation15. Management of Diabetes in Pregnancy: <i>Standards of Care in Diabetes—2024</i>
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s015 · Cited by 232 · see citing works
Yuen, L., Saeedi, P., Riaz, M., Karuranga, S., Divakar, H., Levitt, N. S., Yang, X., & Simmons, D. S. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107841 · Cited by 180 · see citing works
Early onset type 2 diabetes mellitus: an update
Strati, M., Moustaki, M., Ψαλτοπούλου, Θ., Vryonidou, A., & Paschou, S. Α. (2024) · Endocrine · doi:10.1007/s12020-024-03772-w · Cited by 142 · see citing works
Gestational Diabetes Mellitus and Its Implications across the Life Span
Wicklow, B. A., & Retnakaran, R. R. (2023) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2022.0348 · Cited by 126 · see citing works
Developmental overnutrition and obesity and type 2 diabetes in offspring
Perng, W., Oken, E., & Dabelea, D. (2019) · Diabetologia · doi:10.1007/s00125-019-4914-1 · Cited by 111 · see citing works
Nijs, H., & Benhalima, K. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020599 · Cited by 110 · see citing works
Short‐ and long‐term outcomes of gestational diabetes and its treatment on fetal development
Murray, S. R., & Reynolds, R. M. (2020) · Prenatal Diagnosis · doi:10.1002/pd.5768 · Cited by 109 · see citing works
Antoun, E., Kitaba, N. T., Titcombe, P., Dalrymple, K. V., Garratt, E. S., Barton, S. J., Murray, R. J. S., Seed, P. T., Holbrook, J. D., Kobor, M. S., et al. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003229 · Cited by 102 · see citing works
A core outcome set for studies of gestational diabetes mellitus prevention and treatment
Egan, A. M., Bogdanet, D., Griffin, T. P., Kgosidialwa, O., Cervar-Zivkovic, M., Dempsey, E. M., Allotey, J., Alvarado, F., Clarson, C. L., Cooray, S. D., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05123-6 · Cited by 96 · see citing works
Self-citation15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2026
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., Brown, F. M., ChallaSivaKanaka, S., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s015 · Cited by 114 · see citing works
Diagnosis, treatment and prevention of type 2 diabetes mellitus in children and adolescents
Serbis, A., Giapros, V. I., Kotanidou, E. P., Galli-Tsinopoulou, A., & Siomou, E. C. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i4.344 · Cited by 103 · see citing works
García de la Torre, N., Assaf-Balut, C., Jiménez Varas, I., del Valle, L., Durán, A., Fuentes, M., del Prado, N., Bordiú, E., Valerio, J. J., Herraiz, M. A., et al. (2019) · Nutrients · doi:10.3390/nu11061210 · Cited by 88 · see citing works
Gestationsdiabetes (GDM) (Update 2023)
Kautzky‐Willer, A., Winhofer, Y., Kiss, H., Falcone, V., Berger, A., Lechleitner, M., Weitgasser, R., & Harreiter, J. (2023) · Wiener klinische Wochenschrift · doi:10.1007/s00508-023-02181-9 · Cited by 83 · see citing works
A Review of the Pathophysiology and Management of Diabetes in Pregnancy
Egan, A. M., Dow, M. L., & Vella, A. V. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.02.019 · Cited by 74 · see citing works
Genetic and inflammatory factors underlying gestational diabetes mellitus: a review
Ray, G. W., Zeng, Q., Kusi, P., Zhang, H., Shao, T., Yang, T., Wei, Y., Li, M., Che, X., & Guo, R. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1399694 · Cited by 76 · see citing works
Fetal programming of obesity and type 2 diabetes
Seneviratne, S. N., & Rajindrajith, S. (2022) · World Journal of Diabetes · doi:10.4239/wjd.v13.i7.482 · Cited by 58 · see citing works
Barbour, L. A. (2019) · Diabetes Care · doi:10.2337/dci18-0048 · Cited by 57 · see citing works
Exposure to Endocrine-Disrupting Chemicals and Type 2 Diabetes Mellitus in Later Life
Lin, J., & Yin, R. (2022) · Exposure and Health · doi:10.1007/s12403-022-00486-0 · Cited by 54 · see citing works
Updates in Long-term Maternal and Fetal Adverse Effects of Gestational Diabetes Mellitus
Shou, C., Wei, Y.-M., Wang, C., & Yang, H.-X. (2019) · Maternal-Fetal Medicine · doi:10.1097/fm9.0000000000000019 · Cited by 52 · see citing works
Rajamoorthi, A., LeDuc, C. A., & Thaker, V. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1032491 · Cited by 47 · see citing works
Glucose Intolerance in Pregnancy and Offspring Obesity in Late Adolescence
Bendor, C. D., Bardugo, A., Rotem, R. S., Derazne, E., Gerstein, H. C., Tzur, D., Pinhas‐Hamiel, O., Tsur, A. M., Cukierman‐Yaffe, T., Lebenthal, Y., et al. (2022) · Diabetes Care · doi:10.2337/dc21-2634 · Cited by 48 · see citing works
Self-citationZheng, Y., Lin, P. D., Williams, P. L., Weisskopf, M. G., Cárdenas, A., Rifas‐Shiman, S. L., Wright, R. O., Amarasiriwardena, C. J., Henn, B. C., Hivert, M., et al. (2021) · Environment International · doi:10.1016/j.envint.2021.106690 · Cited by 41 · see citing works
The Role of Adiponectin during Pregnancy and Gestational Diabetes
Gruber, B. L. M., & Dolinsky, V. W. (2023) · Life · doi:10.3390/life13020301 · Cited by 40 · see citing works
Mustafa, M., Bogdanet, D., Khattak, A., Carmody, L. A., Kirwan, B., Gaffney, G., O’Shea, P. M., & Dunne, F. (2020) · QJM · doi:10.1093/qjmed/hcaa167 · Cited by 42 · see citing works
Mantzorou, M., Papandreou, D., Pavlidou, E., Papadopoulou, S. Κ., Tolia, M., Mentzelou, M., Poutsidi, A., Antasouras, G., Vasios, G. K., & Giaginis, C. (2023) · Medicina · doi:10.3390/medicina59030455 · Cited by 39 · see citing works
Ayman, G., Strachan, J. A., Mclennan, N., Malouf, R. S., Lowe‐Zinola, J., Magdi, F., Roberts, N. W., Alderdice, F. A., Berneantu, I., Breslin, N., et al. (2021) · Diabetic Medicine · doi:10.1111/dme.14588 · Cited by 39 · see citing works
Zukin, H., Eskenazi, B., Holland, N., & Harley, K. G. (2021) · Environmental Research · doi:10.1016/j.envres.2021.110712 · Cited by 37 · see citing works
Lorenzo, P. I., Martín‐Montalvo, A., Cobo‐Vuilleumier, N., & Gauthier, B. R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246171 · Cited by 37 · see citing works
Plasma Glycated CD59 Predicts Early Gestational Diabetes and Large for Gestational Age Newborns
Ma, D.-D., Luque-Fernández, M. Á., Bogdanet, D., Desoyé, G., Dunne, F., & Halperin, J. A. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa087 · Cited by 38 · see citing works
Yang, L., Huang, C., Zhao, M., Lee, P. M. Y., Zhang, C., Yu, Y., Xi, B., & Li, J. (2023) · BMC Medicine · doi:10.1186/s12916-023-02762-5 · Cited by 36 · see citing works
Prediction of Childhood Obesity from Nationwide Health Records
Rossman, H., Shilo, S., Barbash‐Hazan, S., Artzi, N. S., Hadar, E., Balicer, R. D., Feldman, B., Wiznitzer, A., & Segal, E. (2021) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2021.02.010 · Cited by 35 · see citing works
Gaillard, R., & Jaddoe, V. W. V. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00869-z · Cited by 34 · see citing works
Fadl, H., Saeedi, M., Montgomery, S., Magnuson, A., Schwarcz, E., Berntorp, K., Sengpiel, V., Storck-Lindholm, E., Strevens, H., Wikström, A.-K., et al. (2019) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-019-2547-5 · Cited by 34 · see citing works
The metabolic syndrome in pregnancy and its association with child telomere length
McAninch, D., Bianco‐Miotto, T., Gatford, K. L., Leemaqz, S., Andraweera, P. H., Garrett, A. J., Plummer, M. D., Dekker, G., Roberts, C. T., Smithers, L. G., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05242-0 · Cited by 33 · see citing works
Urinary phthalate and DINCH metabolite concentrations and gradations of maternal glucose intolerance
James-Todd, T. M., Ponzano, M., Bellavia, A., Williams, P. L., Cantonwine, D. E., Calafat, A. M., Hauser, R. B., Quinn, M. R., Seely, E. W., & McElrath, T. F. (2022) · Environment International · doi:10.1016/j.envint.2022.107099 · Cited by 33 · see citing works
Lin, X., Zhang, Y., He, X., Chen, Y., Chen, N., Liu, J., Wang, M., Li, Y., Yang, H., Fan, L., et al. (2021) · Diabetes · doi:10.2337/db21-0188 · Cited by 29 · see citing works
Hill, D. J., & Hill, T. G. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1456629 · Cited by 33 · see citing works
An unwelcome inheritance: childhood obesity after diabetes in pregnancy
Meek, C. L. (2023) · Diabetologia · doi:10.1007/s00125-023-05965-w · Cited by 30 · see citing works
Scholtens, D. M., & Metzger, B. E. (2019) · Diabetes Care · doi:10.2337/dci19-0024 · Cited by 27 · see citing works
Self-citationGestational diabetes ‑ modern management and therapeutic approach (Review)
Sandu, C., Bica, C., Salmen, T., Stoica, R. A., Bohîlțea, R. E., Gherghiceanu, F., Pacu, I., Ștefan, S., Serafinceanu, C., & Stoian, A. P. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.9512 · Cited by 28 · see citing works
Diagnostic Strategies for Gestational Diabetes Mellitus: Review of Current Evidence
Kuo, C., & Li, H. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1271-x · Cited by 26 · see citing works
Bianco, M. E., Kuang, A., Josefson, J. L., Catalano, P. M., Dyer, A. R., Lowe, L. P., Metzger, B. E., Scholtens, D. M., & Lowe, W. L. (2020) · Diabetologia · doi:10.1007/s00125-020-05331-0 · Cited by 25 · see citing works
Self-citationYouth prediabetes and type 2 diabetes: Risk factors and prevalence of dysglycaemia
Saleh, M. W., Kim, J. Y., March, C. A., Gebara, N. Y., & Arslanian, S. A. (2021) · Pediatric Obesity · doi:10.1111/ijpo.12841 · Cited by 26 · see citing works
Daley, B. J., Hitman, G. A., Fenton, N., & McLachlan, S. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-027285 · Cited by 24 · see citing works
Francis, E. C., Dabelea, D., Ringham, B. M., Sauder, K. A., & Perng, W. (2020) · Diabetologia · doi:10.1007/s00125-020-05294-2 · Cited by 24 · see citing works
Genetic Risk Factors and Gene–Lifestyle Interactions in Gestational Diabetes
Jääskeläinen, T. J., & Klemetti, M. M. (2022) · Nutrients · doi:10.3390/nu14224799 · Cited by 25 · see citing works
Venkatesh, K. K., Perak, A. M., Wu, J., Catalano, P. M., Josefon, J. L., Costantine, M. M., Landon, M. B., Lancki, N., Scholtens, D. M., Lowe, W. L., et al. (2024) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2024.04.037 · Cited by 24 · see citing works
Self-citationDiagnosis and Treatment of Hyperglycemia in Pregnancy
Mohan, S., & Egan, A. M. (2024) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2024.05.011 · Cited by 25 · see citing works
Maragkoudaki, X., Naylor, M., Papacleovoulou, G., Stolarczyk, E., Rees, D., Pombo, J., Abu‐Hayyeh, S., Czajka, A., Howard, J. K., Malik, A. N., et al. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-00682-5 · Cited by 25 · see citing works
Self-citationVitacolonna, E., Succurro, E., Lapolla, A., Scavini, M., Bonomo, M. A., Cianni, G. D., Benedetto, A. D., Napoli, A., Tumminia, A., Festa, C., et al. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01397-4 · Cited by 22 · see citing works
Maternal Glucose Concentrations in Early Pregnancy and Cardiometabolic Risk Factors in Childhood
Wahab, R. J., Voerman, E., Jansen, P. W., Oei, E. H. G., Steegers, E. A. P., Jaddoe, V. W. V., & Gaillard, R. (2020) · Obesity · doi:10.1002/oby.22771 · Cited by 22 · see citing works
A Research Roadmap to Address the Heterogeneity of Diabetes and Advance Precision Medicine
Franks, P. W., Rich, S. S., Linder, B. L., Zaghloul, N. A., & Cefalu, W. T. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae844 · Cited by 20 · see citing works
Self-citationJuvinao-Quintero, D. L., Starling, A. P., Cárdenas, A., Powe, C. E., Perron, P., Bouchard, L., Dabelea, D., & Hivert, M. (2021) · Epigenomics · doi:10.2217/epi-2020-0279 · Cited by 20 · see citing works
Mmasa, K. N., Powis, K., Sun, S., Makhema, J., Mmalane, M., Kgole, S. W., Masasa, G., Moyo, S., Gerschenson, M., Mohammed, T., et al. (2021) · HIV Medicine · doi:10.1111/hiv.13120 · Cited by 15 · see citing works
Ling, C., Nie, P., Yao, L., Tang, Y., Hong, W., Liu, W., Fu, F., & Xu, H. (2021) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2021.112814 · Cited by 20 · see citing works
Nattero‐Chávez, L., Luque‐Ramírez, M., & Escobar-Morreale, H. F. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2019.04.039 · Cited by 20 · see citing works
Clark, J. M., Garvey, W. T., Niswender, K. D., Schmidt, A. M., Ahima, R. S., Alemán, J. O., Battarbee, A. N., Beckman, J. A., Bennett, W. L., Brown, N. J., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.027693 · Cited by 20 · see citing works
Martínez‐Hortelano, J. A., Cavero‐Redondo, I., Álvarez‐Bueno, C., Díez‐Fernández, A., Hernández‐Luengo, M., & Martínez‐Vizcaíno, V. (2021) · Obesity · doi:10.1002/oby.23083 · Cited by 19 · see citing works
Mehta, S., James-Todd, T. M., Applebaum, K. M., Bellavia, A., Coleman‐Phox, K., Adler, N. E., Laraia, B. A., Epel, E. S., Parry, E., Wang, M., et al. (2020) · Environmental Research · doi:10.1016/j.envres.2020.110551 · Cited by 18 · see citing works
Prepregnancy Adiposity, Adverse Pregnancy Outcomes, and Cardiovascular Disease Risk in Midlife
Borrowman, J. D., Huang, X., Petito, L. C., Perak, A. M., Scholtens, D. M., Lowe, W. J., Lloyd‐Jones, D. M., Grobman, W. A., & Khan, S. S. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.02.033 · Cited by 18 · see citing works
Self-citationFlanagan, E. W., Most, J., Broskey, N. T., Altazan, A. D., Beyl, R. A., Keadle, S. K., Drews, K. L., Singh, P., & Redman, L. M. (2020) · Sleep Medicine · doi:10.1016/j.sleep.2020.11.031 · Cited by 18 · see citing works
The intestine and the microbiota in maternal glucose homeostasis during pregnancy
Yeo, E., Brubaker, P. L., & Sloboda, D. M. (2022) · Journal of Endocrinology · doi:10.1530/joe-21-0354 · Cited by 19 · see citing works
Maternal gestational diabetes mellitus and risk of allergic diseases in offspring
Hsu, M.-C., Lin, C., & Lin, M. (2023) · Pediatrics & Neonatology · doi:10.1016/j.pedneo.2023.06.012 · Cited by 18 · see citing works
Scifres, C., Mead‐Harvey, C., Nadeau, H. C. G., Reid, S., Pierce, S., Feghali, M. N., Myers, D. A., Fields, D. A., & Stoner, J. A. (2019) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2019.100050 · Cited by 18 · see citing works
Greff, D., Váncsa, S., Váradi, A., Szinte, J., Park, S., Hegyi, P., Nyírády, P., Ács, N., Horvath, E. M., & Várbı́ró, S. (2023) · Nutrients · doi:10.3390/nu15194224 · Cited by 18 · see citing works
Wu, Q., Chen, Y., Ma, H., Zhou, T., Hu, Y., Liang, Z., & Chen, D. (2023) · Nutrition & Diabetes · doi:10.1038/s41387-023-00239-1 · Cited by 16 · see citing works
Wang, Z., Luo, J., Zhang, Y., Li, J., Zhang, J., Tian, Y., & Gao, Y. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.160130 · Cited by 16 · see citing works
Maternal Early‐Pregnancy Glucose Concentrations and Liver Fat Among School‐Age Children
Geurtsen, M. L., Wahab, R. J., Felix, J. F., Gaillard, R., & Jaddoe, V. W. V. (2021) · Hepatology · doi:10.1002/hep.31910 · Cited by 17 · see citing works
Lindsay, K. L., Gyllenhammer, L. E., Entringer, S., & Wadhwa, P. D. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab655 · Cited by 16 · see citing works
Assessment of Eating Behaviors and Perceptions of Time-Restricted Eating During Pregnancy
Flanagan, E. W., Kebbe, M., Sparks, J. R., & Redman, L. M. (2021) · Journal of Nutrition · doi:10.1093/jn/nxab397 · Cited by 16 · see citing works
Perng, W., Kelsey, M. M., Sauder, K. A., & Dabelea, D. (2021) · Diabetologia · doi:10.1007/s00125-021-05515-2 · Cited by 15 · see citing works
Integrated care of diabetes during pregnancy: a Qatari nationwide cohort
Bashir, M., Ibrahim, I., Beer, S. F., Shahbic, H., Taher, F. E., Al-Mutawaa, K., Zirie, M. A., & Abou‐Samra, A. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102605 · Cited by 14 · see citing works
Hyperglycemia at 1h-OGTT in Pregnancy: A Reliable Predictor of Metabolic Outcomes?
Succurro, E., Fraticelli, F., Franzago, M., Fiorentino, T. V., Andreozzi, F., Vitacolonna, E., & Sesti, G. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.612829 · Cited by 14 · see citing works
Yajnik, C. S., & Yajnik, P. (2020) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa122 · Cited by 14 · see citing works
The possible role of endocrine dysfunction of adipose tissue in gestational diabetes mellitus
Šimják, P., Anderlová, K., Cinkajzlová, A., Pařı́zek, A., Kršek, M., & Haluzı́k, M. (2020) · Minerva Endocrinology · doi:10.23736/s0391-1977.20.03192-2 · Cited by 16 · see citing works
Beldie, L.-A., Dica, C.-C., Moța, M., Pirvu, B.-F., Burticală, M.-A., Mitrea, A., Clenciu, D., Efrem, I. C., Vladu, B. E., Timofticiuc, D. C. P., et al. (2024) · Nutrients · doi:10.3390/nu16234131 · Cited by 16 · see citing works
Genetics and epigenetics in gestational diabetes contributing to type 2 diabetes
Kong, D., Kowalik, O., Garratt, E. S., Godfrey, K. M., Chan, S., & Teo, A. K. K. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2025.03.014 · Cited by 14 · see citing works
Wahab, R. J., Jaddoe, V. W. V., Roest, A. A. W., Toemen, L., & Gaillard, R. (2020) · Diabetes Care · doi:10.2337/dc19-2580 · Cited by 13 · see citing works
Wu, D., Zhang, J., Xiong, Y.-M., Wang, H., Lu, D., Guo, M., Zhang, J., Chen, L., Fan, J., Huang, H., et al. (2022) · Nutrients · doi:10.3390/nu14163295 · Cited by 13 · see citing works
Athanasiadou, K. I., Paschou, S. Α., Markozannes, G., Vasileiou, V., Kanouta, F., Mitropoulou, M., Antsaklis, P. G., Theodora, M., Ψαλτοπούλου, Θ., Daskalakis, G. J., et al. (2025) · Endocrine · doi:10.1007/s12020-025-04329-1 · Cited by 12 · see citing works
Life-course management of gestational diabetes mellitus: A narrative review
Luo, Q.-J., & Ni, Q. (2025) · World Journal of Clinical Cases · doi:10.12998/wjcc.v13.i29.111096 · Cited by 14 · see citing works
Adiponectin agonist treatment in diabetic pregnant rats
Gázquez, A., Rodríguez, F., Sánchez-Campillo, M., Gascón, L. M., Arnao, M. B., Saura-Garre, P., Albaladejo-Otón, M. D., & Larqué, E. (2021) · Journal of Endocrinology · doi:10.1530/joe-20-0617 · Cited by 11 · see citing works
Deng, Y., Jin, H., Ning, J., Cui, D., Zhang, M., & Yang, H. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00707-5 · Cited by 12 · see citing works
Bline, A. P., Ellis, L. B., Pelch, K. E., Lam, J., Sen, Ś., Zlatnik, M. G., & Varshavsky, J. (2024) · Environment International · doi:10.1016/j.envint.2024.108711 · Cited by 13 · see citing works
- Authors
- Scholtens, D. M., Kuang, A., Lowe, L. P., Hamilton, J., Lawrence, J. M., Lebenthal, Y., Brickman, W. J., Clayton, P., Ma, R. C., McCance, D., Tam, W. H., Catalano, P. M., Linder, B., Dyer, A. R., Lowe, W. L., Metzger, B. E., HAPO Follow-Up Study Cooperative Research Group, Deerochanawong, C., Tanaphonpoonsuk, T., Chotigeat, S. B. U., Manyam, W., Forde, M., Greenidge, A., Neblett, K., Lashley, P. M., Walcott, D., Corry, K., Francis, L., Irwin, J.-A., Langan, A., McCance, D. R., Mousavi, M., Young, I., Gutierrez, J., Jimenez, J., Lawrence, J. M., Sacks, D. A., Takhar, H. S., Tanton, E., Brickman, W. J., Howard, J., Josefson, J. L., Miller, L., Bjaloncik, J., Catalano, P. M., Davis, A., Koontz, M., Presley, L., Smith, S., Tyhulski, A., Li, A. M., Ma, R. C., Ozaki, R., Tam, W. H., Wong, M., Yuen, C. S. M., Clayton, P. E., Khan, A., Vyas, A., Maresh, M., Benzaquen, H., Glickman, N., Hamou, A., Hermon, O., Horesh, O., Keren, Y., Lebenthal, Y., Shalitin, S., Cordeiro, K., Hamilton, J., Nguyen, H. Y., Steele, S., Chen, F., Dyer, A. R., Huang, W., Kuang, A., Jimenez, M., Lowe, L. P., Lowe, W. L., Metzger, B. E., Nodzenski, M., Reisetter, A., Scholtens, D., Talbot, O., Yim, P., Dunger, D., Thomas, A., Horlick, M., Linder, B., Unalp-Arida, A., & Grave, G.
- Affiliations
- Northwestern University Feinberg School of Medicine, Chicago, IL
- Royal Manchester Children’s Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Healthy Sciences Centre, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, U.K.
- Royal Victoria Hospital, Belfast, U.K.
- Royal Victoria Hospital (GB)
- National Institutes of Health (US)
- Northwestern University (US)
- Tel Aviv University (IL)
- ORCID
- McCance, David
- Deerochanawong, Chaicharn
- Lashley, Paula Michele
- Langan, Anne
- Young, Ian
- Sacks, David A.
- Takhar, Harpreet S.
- Josefson, Jami L.
- Miller, Lauren
- Li, Albert Martin
- Ozaki, Risa
- Khan, Aysha
- Vyas, Avni
- Maresh, Michael
- Shalitin, Shlomit
- Cordeiro, Kristina
- Chen, Fei
- Huang, Wenyu
- Nodzenski, Michael
- Reisetter, Anna
- Talbot, Octavious
- Dunger, David
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2019-01-07
- Volume
- 42
- Issue
- 3
- Pages
- 381-392
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC6385697
- OpenAlex
- W2908159319
- Cited by
- 310
- References
- 41
- Citations by year
- 2026: 41 · 2025: 46 · 2024: 49 · 2023: 37 · 2022: 46 · 2021: 37 · 2020: 32 · 2019: 22
- FWCI
- 37.24
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes Care (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (submittedVersion, other-oa)
- Funders
- National Institute for Health and Care Research (NF-SI-0513-10012)
- National Institutes of Health (UL1TR001422, UL1TR002548)
- National Institute of Diabetes and Digestive and Kidney Diseases (U01DK094830)
- National Center for Advancing Translational Sciences
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD034242, R01HD034243)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
- Keywords
- maternal glycemia, hyperglycemia in pregnancy, impaired fasting glucose, impaired glucose tolerance, insulin resistance, insulin sensitivity, disposition index, HbA1c, fasting blood glucose, oral glucose tolerance test, prenatal exposure, offspring diabetes risk
- MeSH terms
- Adolescent, Adult, Blood Glucose, Child, Diabetes Mellitus, Female, Follow-Up Studies, Glucose Tolerance Test, Humans, Hyperglycemia, Insulin Resistance, Male, Middle Aged, Prediabetic State, Pregnancy, Pregnancy Complications, Pregnancy in Diabetics, Pregnancy Outcome, Prenatal Exposure Delayed Effects, Cohort Studies, Child of Impaired Parents, Glucose Intolerance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-07.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-07.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review